Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion type Assertion NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_head.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion description "[The presence of TAP2D was greatly increased in HLA-B44/DR4 positive RA (83%) and FS (67%) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_provenance.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion evidence source_evidence_literature NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_provenance.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion SIO_000772 8697660 NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_provenance.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion wasDerivedFrom befree-20140225 NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_provenance.
- NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_assertion wasGeneratedBy ECO_0000203 NP435317.RAmOHHQTYxMr4ECK4689hRTNIMh1lQahKn-IYHbbj4108130_provenance.